Skip to main content
Clinical Trials/NCT02459717
NCT02459717
Completed
Not Applicable

Double Blind, Placebo-controlled Trial of a Fermented Milk Containing Multiple Probiotics Strains and Prebiotic Fiber for Constipation Associated With Parkinson's Disease

Emanuele Cereda1 site in 1 country120 target enrollmentJune 2015
ConditionsConstipation

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Constipation
Sponsor
Emanuele Cereda
Enrollment
120
Locations
1
Primary Endpoint
Complete bowel movements
Status
Completed
Last Updated
last year

Overview

Brief Summary

Constipation is the most frequent (prevalence, about 60%) dysautonomic non motor symptom affecting Parkinson's disease (PD) patients. Unfortunately, limited treatment options have been investigated and are now available for the management of constipation in PD. Preliminary data have suggested that probiotics could be help improving bowel habits but high-quality randomized trials are required in this area. Therefore, the investigators designed a randomized trial to evaluate whether the use of a fermented milk containing multiple probiotics strains and prebiotic fiber have a beneficial effect on constipation in PD compared to placebo.

Registry
clinicaltrials.gov
Start Date
June 2015
End Date
October 2015
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Emanuele Cereda
Responsible Party
Sponsor Investigator
Principal Investigator

Emanuele Cereda

Co-project Investigator

Fondazione IRCCS Policlinico San Matteo di Pavia

Eligibility Criteria

Inclusion Criteria

  • diagnosis of constipation according to Roma III criteria
  • complete bowel movements per week \<3
  • total bowel movements per week \<6
  • written informed consent

Exclusion Criteria

  • report of loose (mushy) or watery stool in the absence of laxative use
  • ongoing artificial nutrition
  • lactose intolerance
  • chronic inflammatory bowel disease
  • previous abdominal surgery
  • use of anti-cholinergics
  • use of antibiotics in the 6 weeks before baseline visit
  • Radio- chemotherapy
  • Cognitive decline (Mini Mental State Examination \<27)

Outcomes

Primary Outcomes

Complete bowel movements

Time Frame: 4 weeks

Change in the mean number of complete spontaneous bowel movements

Secondary Outcomes

  • Stool consistency(4 weeks)
  • Number of bowel movements(4 weeks)
  • Treatment satisfaction(4 weeks)
  • Frequency of three or more complete bowel movements(4 weeks)
  • Laxative use(4 weeks)
  • Treatment continuation(4 weeks)
  • Increase in one or more complete bowel movements(4 weeks)

Study Sites (1)

Loading locations...

Similar Trials